TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
IMCR

Immunocore Holdings Ltd

Healthcare · Biotechnology

30.30$ -1.8% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement IMCR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +79.6% +43.7% -12.2% +63.7% +8.5% +17.3% -10.2% +433.3% +36.9% +25.6% +20.0%
– – – – – – -25.2% -0.9% -92.9% -84.5% +575.6% +12.1%
– +79.6% +43.7% -12.2% +63.7% -414.2% – – +413.7% +41.5% +23.3% +20.2%
– +81.3% +108.0% +32.9% +36.7% +19.6% -25.2% -0.7% +13.5% +53.5% +37.1% +15.2%
– +20.8% +25.5% +487.8% +55.1% +29.4% +3.5% +160.8% -21.4% +65.2% +0.6% +6.2%
– +83.5% +94.9% +69.3% +42.1% -62.6% -5.7% +277.0% +16.1% +34.1% +22.6% +8.8%
– – – – – – – – – – – –
– – – – – +350.8% -18.1% +79.3% -2.9% -24.6% +362.0% -35.4%
– – -316.5% – – – – – – – – –
– -39.8% +741.4% +95.7% -204.6% – -159.6% – +8,574.6% -146.0% – –
– – -271.9% – – – – – – – – –
– – – – – – – – – – – –

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?